Literature DB >> 10521269

Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis.

S Parikh1, D P Moynihan, G Xiao, P J Tonge.   

Abstract

The role of tyrosine 158 (Y158) and lysine 165 (K165) in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis, has been investigated. These residues have been identified as putative catalytic residues on the basis of structural and sequence homology with the short chain alcohol dehydrogenase family of enzymes. Replacement of Y158 with phenylalanine (Y158F) and with alanine (Y158A) results in 24- and 1500-fold decreases in k(cat), respectively, while leaving K(m) for the substrate, trans-2-dodecenoyl-CoA, unaffected. Remarkably, however, replacement of Y158 with serine (Y158S) results in an enzyme with wild-type activity. Kinetic isotope effect studies indicate that the transfer of a solvent-exchangeable proton is partially rate-limiting for the wild-type and Y158S enzymes, but not for the Y158A enzyme. These data indicate that Y158 does not function formally as a proton donor in the reaction but likely functions as an electrophilic catalyst, stabilizing the transition state for hydride transfer by hydrogen bonding to the substrate carbonyl. A conformational change involving rotation of the Y158 side chain upon binding of the enoyl substrate to the enzyme is proposed as an explanation for the inverse solvent isotope effect observed on V/K(DD-CoA) when either NADH or NADD is used as the reductant. These data are consistent with the recently published structure of a C16 fatty acid substrate bound to InhA that shows Y158 hydrogen bonded to the substrate carbonyl group and rotated from the position it occupies in the InhA-NADH binary complex [Rozwarski, D. A., Vilcheze, C., Sugantino, M., Bittman, R., and Sacchettini, J. C. (1999) J. Biol. Chem. 274, 15582-15589]. Finally, the role of K165 has been analyzed using site-directed mutagenesis. Replacement of K165 with glutamine (K165Q) and arginine (K165R) has no effect on the enzyme's catalytic ability or on its ability to bind NADH. However, the K165A and K165M enzymes are unable to bind NADH, indicating that K165 has a primary role in cofactor binding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10521269     DOI: 10.1021/bi990529c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

1.  Substrate recognition by the human fatty-acid synthase.

Authors:  Loretha Carlisle-Moore; Chris R Gordon; Carl A Machutta; W Todd Miller; Peter J Tonge
Journal:  J Biol Chem       Date:  2005-10-07       Impact factor: 5.157

2.  Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).

Authors:  Jiangwei Yao; John B Maxwell; Charles O Rock
Journal:  J Biol Chem       Date:  2013-11-04       Impact factor: 5.157

3.  Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.

Authors:  Shahila Mehboob; Kent Truong; Bernard D Santarsiero; Michael E Johnson
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-27

4.  Characterization of Streptococcus pneumoniae enoyl-(acyl-carrier protein) reductase (FabK).

Authors:  Hedia Marrakchi; Walter E Dewolf; Chad Quinn; Joshua West; Brian J Polizzi; Chi Y So; David J Holmes; Shannon L Reed; Richard J Heath; David J Payne; Charles O Rock; Nicola G Wallis
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

5.  Direct inhibitors of InhA are active against Mycobacterium tuberculosis.

Authors:  Ujjini H Manjunatha; Srinivasa P S Rao; Ravinder Reddy Kondreddi; Christian G Noble; Luis R Camacho; Bee H Tan; Seow H Ng; Pearly Shuyi Ng; Ng L Ma; Suresh B Lakshminarayana; Maxime Herve; Susan W Barnes; Weixuan Yu; Kelli Kuhen; Francesca Blasco; David Beer; John R Walker; Peter J Tonge; Richard Glynne; Paul W Smith; Thierry T Diagana
Journal:  Sci Transl Med       Date:  2015-01-07       Impact factor: 17.956

6.  Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli.

Authors:  Salma Rafi; Polina Novichenok; Subramaniapillai Kolappan; Christopher F Stratton; Richa Rawat; Caroline Kisker; Carlos Simmerling; Peter J Tonge
Journal:  J Biol Chem       Date:  2006-09-29       Impact factor: 5.157

7.  Crystal structure and biochemical studies of the trans-acting polyketide enoyl reductase LovC from lovastatin biosynthesis.

Authors:  Brian D Ames; Chi Nguyen; Joel Bruegger; Peter Smith; Wei Xu; Suzanne Ma; Emily Wong; Steven Wong; Xinkai Xie; Jesse W-H Li; John C Vederas; Yi Tang; Shiou-Chuan Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

8.  A [(32)P]NAD(+)-based method to identify and quantitate long residence time enoyl-acyl carrier protein reductase inhibitors.

Authors:  Weixuan Yu; Carla Neckles; Andrew Chang; Gopal Reddy Bommineni; Lauren Spagnuolo; Zhuo Zhang; Nina Liu; Christina Lai; James Truglio; Peter J Tonge
Journal:  Anal Biochem       Date:  2015-02-14       Impact factor: 3.365

9.  Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan.

Authors:  Mili Kapoor; C Chandramouli Reddy; M V Krishnasastry; Namita Surolia; Avadhesha Surolia
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

10.  Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.

Authors:  Hao Lu; Peter J Tonge
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.